Clinical Trials

38 enrolled

Adenomatous Polyposis Coli, Colorectal Neoplasms

NCT06732388 2026-03-18

Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus

64 enrolled

Adenocarcinoma Of Esophagus, Barrett Esophagus

NCT06735638 2026-03-18

Outside the Cage (OTC) Robotic Esophagectomy

31 enrolled

Esophageal Neoplasms, Ornithine Carbamoyltransferase Deficiency Disease

NCT07464236 2026-03-18

PEACHES 2

8 enrolled

Anus Neoplasms, Chlamydia Infections, Gonorrhea

NCT07470268 2026-03-18

HY-PANC

10 enrolled

Motor Activity, Pancreatic Neoplasms

NCT07472933 2026-03-18

Vebotolimab Combined With Ptorlimab for EGFR-positive Refractory Advanced Biliary Tract Malignancies

44 enrolled

Cancer of Biliary Duct

NCT07479485 2026-03-18

MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II)

160 enrolled

Carcinoma, Hepatocellular

NCT07481032 2026-03-18

Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis: A Multicenter, Randomized, Placebo-controlled Study

1,034 enrolled

Carcinoma, Hepatocellular, Liver Cirrhosis, Hepatitis B, Chronic

NCT07481357 2026-03-18

A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma

51 enrolled

Stomach Neoplasms

NCT07476651 2026-03-17

LASER

30 enrolled

Carcinoma, Hepatocellular, Cholangiocarcinoma

NCT07477444 2026-03-17

HER-OIC

29 enrolled

Gastroesophageal Cancer

NCT07478185 2026-03-17

Prehab for Pancreatic Cancer Surgery

20 enrolled

Pancreatic cancer, adult, Pancreatic Neoplasms

NCT07478523 2026-03-17

FAPDIG

120 enrolled

Cholangiocarcinoma

NCT07416552 2026-03-16

A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)

180 enrolled

Colorectal Neoplasms

NCT07419841 2026-03-16

A Phase 1 Study of the Safety and Tolerability of CTX-10726

GastrointestinalGenitourinaryGynecologic

70 enrolled

Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Endometrial Neoplasms

NCT07469306 2026-03-13

Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer

130 enrolled

Locally Advanced Rectal Cancer

NCT07469956 2026-03-13

Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer

30 enrolled

Pancreatic Neoplasms

NCT07296887 2026-03-12

CARE Tool Study Aim 3

GastrointestinalGenitourinaryThoracic

430 enrolled

Financial Stress, Lung Neoplasms, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT07391670 2026-03-12

IMFINZI-subQ

40 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular, Small Cell Lung Carcinoma

NCT07411599 2026-03-12

Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial")

28 enrolled

Colorectal Cancer, Hereditary Nonpolyposis, Type 6, Carcinoma, Colorectal Neoplasms

NCT07436988 2026-03-12

ReLIVE

18 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT07450976 2026-03-12

A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer

151 enrolled

Phase 4 Not yet recruiting

Biliary Tract Neoplasms

NCT07467174 2026-03-12

REPROG-RCT

538 enrolled

Stomach Neoplasms

NCT07467590 2026-03-12

TRIUNITE-07

33 enrolled

Colorectal Neoplasms

NCT07468071 2026-03-12

KontRASt-R

40 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT07381634 2026-03-11

The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities

134 enrolled

Carcinoma, Hepatocellular

NCT07463248 2026-03-11

PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy

64 enrolled

Carcinoma, Hepatocellular

NCT07463261 2026-03-11

RELOAD

442 enrolled

Phase 3 Not yet recruiting

Rectal Neoplasms, Anastomotic Leak

NCT07463573 2026-03-11

QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma

466 enrolled

Esophageal Squamous Cell Carcinoma

NCT07463690 2026-03-11

Construction and Evaluation of a Flipped Discharge Model for Stomates With Colorectal Cancer

200 enrolled

Colorectal Neoplasms

NCT07464756 2026-03-11

SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer

80 enrolled

Gastric Adenocarcinoma

NCT07464769 2026-03-11

KompXX

Phase 3 Not yet recruiting

358 enrolled

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

NCT07461675 2026-03-10

Effects of Neoadjuvant Immunotherapy on Anti-tumour Immunity in Hepatocellular Carcinoma Patients Undergoing Liver Resection

30 enrolled

Phase 2/3 Not yet recruiting

Carcinoma, Hepatocellular

NCT07462143 2026-03-10

A Phase Ⅱ/Ⅲ Clinical Trial of RC148 Plus Chemotherapy as 1L Therapy for Unresectable or Metastatic Colorectal Cancer

700 enrolled

Colonic Neoplasms

NCT07459309 2026-03-09

Clinical Study on the Safety, Efficacy, and Exploration of Immune Mechanisms of a Combined Multimodal Tumor Therapy System for Hepatic Malignancies

20 enrolled

Liver Neoplasms, Neoplasm Metastasis

NCT07191418 2026-03-06

Spearmint

178 enrolled

Pancreatic Cancer Metastatic to Liver

NCT07436637 2026-03-06

Guardant Shield Colorectal Cancer Screening

500 enrolled

Colorectal Neoplasms

NCT07453394 2026-03-06

QLS5132 Combination Therapy in Advanced Solid Tumors

GastrointestinalGynecologicThoracic

626 enrolled

Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT07453797 2026-03-06

VISION

150 enrolled

Colorectal Neoplasms

NCT07453875 2026-03-06

TRIUNITE06

9 enrolled

Phase 2/3 Not yet recruiting

Colorectal Neoplasms

NCT07454720 2026-03-06

A Randomized, Double-blind, Placebo-controlled, Multicenter Phase II/III Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer

165 enrolled

Locally Advanced Resectable Rectal Cancer

NCT07455422 2026-03-06

Endeavor-2

266 enrolled

Adenocarcinoma, Barrett Esophagus

NCT05038098 2026-03-05

Magnetic Sentinel Lymph Node Mapping in Gastric Cancer

20 enrolled

Gastric Adenocarcinoma

NCT07452471 2026-03-05

TAP-WELPASS

80 enrolled

Pain, Postoperative, Stomach Neoplasms

NCT07452601 2026-03-05

Time-of-Day of Immunotherapy Infusion in Neoadjuvant Immunochemotherapy for Thoracic ESCC

90 enrolled

Esophageal Squamous Cell Carcinoma

NCT07453173 2026-03-05

ONCO-RET

15 enrolled

Locally Advanced Rectal Cancer

NCT07444541 2026-03-03

ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer

84 enrolled

Pancreatic Neoplasms

NCT07446049 2026-03-03

A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression

BreastGastrointestinalGynecologicThoracic

180 enrolled

Breast Neoplasms, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT07446257 2026-03-03

THIO and Cadonilimab in Resectable Hepatocellular Carcinoma

Phase EARLY_PHASE1 Not yet recruiting

60 enrolled